ACE2 and COVID-19: In addition to the direct effects of SAR-CoV-2, the immune and inflammatory factors associated with the pathogenesis of COVID-19, the imbalance and downregulation between the ACE2/angiotensin-(1–7)/MAS and RAS after infection may also promote multiple organ injury in COVID-19 [3].